Wide Range of resources on complex issues

We offer a wide range of resources on complex issues that impact all people with chronic conditions. Resources include member-specific services, frequent meetings and events, publications, and comments on rules and legislation.

Guest Blog: The Biosimilars Council Launches a New Educational Resource for Patients

07/11/2022

Guest Blog: The Biosimilars Council Launches a New Educational Resource for Patients By: Erica Klinger, Senior Director, Marketing, Association for Accessible Medicines (AAM) Today, many

NHC Testifies at IRS Hearing on the ACA “Family Glitch”

07/07/2022

NHC Testifies at IRS Hearing on the ACA “Family Glitch” By: Jennifer Dexter, AVP, Policy Financial assistance to buy health insurance on the Affordable Care

Help Raise Awareness for These Causes in July

07/05/2022

Help Raise Awareness for These Causes in July By Jennifer Schleman, VP, Marketing Communications Awareness months allow the opportunity to educate, promote, advocate, and raise

Advancing Patient Involvement: An Update on the NHC’s Strategic Plan Implementation

06/30/2022

Advancing Patient Involvement: An Update on the NHC’s Strategic Plan Implementation By: Randall Rutta, Chief Executive Officer The mission of the National Health Council (NHC)

Important FDA Legislation Advances in U.S. House and Senate

06/27/2022

Important FDA Legislation Advances in U.S. House and Senate By: Jennifer Dexter, AVP, Policy  The Prescription Drug User Fee Act (PDUFA) was created by Congress

The NHC Invites Members to Participate in Survey on Research & Programs Offerings

06/24/2022

The NHC Invites Members to Participate in Survey on Research & Programs Offerings By: Omar A. Escontrías, DrPH, MPH, Vice President, Research, Education & Programs

NHC Comments on Hospital Inpatient Prospective Payment Systems

06/17/2022

NHC Comments on Hospital Inpatient Prospective Payment Systems (PDF) June 17, 2022 Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health and

NHC Provides Comments on FDA Guidance to Increase Diversity of Clinical Trials

06/16/2022

Add Your Heading Text Here Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Other Blogs:

NHC Comments on FDA Diversity in Clinical Trials Guidance

06/13/2022

NHC Comments on FDA Diversity in Clinical Trials Guidance (PDF) June 13, 2022 The Honorable Robert M. Califf, M.D. Commissioner U.S. Food and Drug Administration